Sandbox:Sahar: Difference between revisions
Jump to navigation
Jump to search
(Blanked the page) Tag: Blanking |
No edit summary |
||
| Line 1: | Line 1: | ||
{{familytree/start |summary=Sample 8}}{{familytree/start |summary=PE diagnosis Algorithm.}} | |||
{{familytree/start}} | |||
{{familytree | | | | | | | | | | | | | | A01 | | |A01='''COVID-19 infection'''}} | |||
{{familytree | | | | | | | | | | B01 |-|.|!|,|-| B02 | | | | | | | |B01=ACE-2 receptor involvement|B02=Increased Angiotensin II}} | |||
{{familytree | | | | | | C01 |-|-|-|-|-| C02 |-|-|-|-|-| C03 | | | |C01=Altered coagulation biomarkers|C02=COVID-19 Coagulopathy|C03=Increased inflammatory markers}} | |||
{{familytree | | | | | | | | | | D01 |-|'|!|`|-| D02 | | | | | | | |D01=Endothelial injury|D02=Coagulation cacade activation}} | |||
{{familytree | | | | | | | | | | | | | | E01 | | | | | | | | | | | |E01=Transient increase in antiphospholipid Abs}} | |||
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | |||
{{familytree/end}} | |||
Revision as of 21:17, 6 August 2020
| COVID-19 infection | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ACE-2 receptor involvement | Increased Angiotensin II | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Altered coagulation biomarkers | COVID-19 Coagulopathy | Increased inflammatory markers | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Endothelial injury | Coagulation cacade activation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Transient increase in antiphospholipid Abs | |||||||||||||||||||||||||||||||||||||||||||||||||||||||